BICO Group companies CELLINK, global leader in developing and delivering life-science solutions, and Nanoscribe, the market leader in 3D printing on the nano-, micro-, and mesoscale, announced the launch of the Quantum X bio, a revolutionary printing platform providing researchers with first-of-its-kind submicron bioprinting resolution. It runs on Two-Photon Polymerization (2PP)
“Co-developing products like this is the exact reason why we take such pride in being a part of the BICO group. We look forward to delivering this system to our customers and witnessing the marvelous breakthroughs they will achieve.”
– Cecilia Edebo, CEO of CELLINK
Quantum X bio Printing Platform
The Quantum X bio, touted as the world’s most accurate 3D bioprinter is powered by Two-Photon Polymerization (2PP). It is the premier tool for miniaturizing bioprinting, redefining what it means to work within advanced biomedical applications, including tissue engineering and regenerative medicine. It combines CELLINK’s bioprinting expertise with the engineering excellence of Nanoscribe to create a first-of-Its-kind bioprinter
Building off the revolutionary Nanoscribe Quantum X platform of printers, the Quantum X bio enables print resolution down to 100 nanometers and allows researchers to fabricate advanced microenvironments for tissue engineering, custom scaffolds for cell studies, detailed microfluidic elements and microneedle arrays or microrobots for drug delivery. With its easy-to-learn user interface and straightforward workflow, the Quantum X bio an optimal tool for researchers.
Grounded in Nanoscribe’s engineering excellence, the proprietary technology is customized and reimagined through collaboration with the bioprinting experts at CELLINK, implementing essential features like precise temperature control, sterile environment and functionalized biomaterials. Additionally, the bioprinter unlocks a new level of resolution in bio fabrication and effectively accelerates innovation across critical applications like tissue engineering, smart hydrogel materials, drug delivery, mechanobiology and vascularized tissue.
“Our industry-proven Two-Photon Polymerization technology, combined with CELLINK’s bioprinting expertise, will be a game changer for many challenging biological and biomedical applications, and we look forward to expanding our market leading 3D Microfabrication position in the life sciences with a dedicated bioprinter. The launch of Quantum X bio confirms the power of collaboration within the BICO Group, and we are excited to unlock the full potential at the merger of technical and life science disciplines.”
– Martin Hermatschweiler, CEO of Nanoscribe
Companies and organizations interested in the Quantum X bio can find more information at official CELLINK and Nanoscribe websites.
About Manufactur3D Magazine: Manufactur3D is an online magazine on 3D Printing. Visit our Tech News page for more updates on Global 3D Printing News. To stay up-to-date about the latest happenings in the 3D printing world, like us on Facebook or follow us on LinkedIn and Twitter.
